Username:
Password:
Save My Information  |  Forgot?
Home  |   IIR Energy  |   Industrial Info Europe  |   Multi-Media Center  |   What's New  |   About Us  |   Contact Us
Market Coverage  |   Databases  |   Industry Analytics  |   Tools  |   Multi-Media Services  |   Online Store

  Premium News Article  

India's Biocon Secures Spot in List of Top Global Biotech Majors

BANGALORE, INDIA--July 25, 2008--Researched by Industrial Info Resources (Sugar Land, Texas)--A recent report released by Med Ad News ranked Biocon Limited (Bangalore, Karnataka), India's pioneer in the biotechnology space, among the world's top 25 biotechnology companies. The report, which listed drug-based firms by revenue and by income, ranked Biocon at 20. Biocon has the distinction of being the only Asian country to be featured in the league, which includes 19 U.S. companies and five others from Europe and Australia. Firms from across the world have begun to take interest in India's biotechnology industry, including Eli Lilly (NYSE:LLY) and Sigma-Aldrich Corporation (NASDAQ:SIAL). Johnson & Johnson (NYSE:JNJ) and Novartis (NYSE:NVS) are among several major companies that already have a presence in the country.

Other companies featured: Bayer AG (OTC:BAYRY), Syngenta (NYSE:SYT), Monsanto (NYSE:MON), Daiichi Sankyo (TYO:4568), Covance Incorporated (NYSE:CVD), GlaxoSmithKline (NYSE:GSK), Pfizer (NYSE:PFE)

Read the Complete Article >>>

Details on this Article:
Industry Segment: Pharmaceutical & Biotech
Word Count: 956 Words

Listen to Today's News News Audio Library Sync News Podcasts

  Login or Register now for instant access!

Username:        Password:     


Related Articles

Premium News Article  Value of Industrial Project Starts in North America at $150 Billion for 200...

Free News Article  Industrial Info's World Expansion Helps Clients Uncover New Business Opport...

Free News Article  Project Management Excellence Promotes Project Success, by Pathfinder LLC, ...

Premium News Article  Weird Science? Big Pharma's Top Three M&A Deals in 2009 Nears $160 Billion

Premium News Article  Baltimore's Cel-Sci to Begin Production in $22 Million Aseptic Biopharma Pl...




This article is available for Premium Members only.

Subscribe Now! All Fields are Required...

First Name:
Last Name:
E-Mail Address:
Desired Username:
Password:
Confirm Password:
Subscription Type:
Pricing Help?
Pay-Per-Article - $5.95
Annual Premium News - $235.00
Annual Premium News with Archive - $395.00
 

Upgrade your Premium News Subscription to include all archived articles for only $160. Contact Member Services: 800-762-3361

All Members Receive the Following Free Resources:
  • North American Project & Gap Spending
  • North American Plant Analysis by Industry & Market Region
  • Market Maps & Stats - Capital & Maintenance Activity
  • Current & Historic Economic Indicators
  • 30/60/90 Day Weather Forecast



  • © 2010 ALL RIGHTS RESERVED. Industrial Info Resources, Inc. - Sugar Land, TX - 800-762-3361 Back to Top